news + events

New Jersey universities are developing leading discoveries and innovations in today’s top life sciences and biotech industries. The Life Sciences Innovation Showcase at Princeton Innovation Center BioLabs will present early-stage companies and new technologies coming through their tech transfer offices.

This invitation-only event will provide an opportunity for tech transfer offices, founders, investors and ecosystem partners to gather for a day of short pitches, resource talks, fireside chat, and carefully curated networking.

Participating tech transfer offices will be asked to identify their most exciting life sciences companies or technologies and either present them themselves or invite the inventors or founders to do so.

For more information, click here. 

Join us at the New Jersey Bioscience Center for insights into alternative sources of funding to advance life sciences companies in New Jersey.

This panel discussion will focus on securing funding from non-traditional sources, and will address the following questions:

• How will the next generation of drugs, diagnostics, and devices be funded?
• What new models are there that might change the paradigm?
• Is there a better way to fund early and emerging commercial biomedical research?

Panelists Include:

• Josh Barer, Managing Director at Hibiscus BioVentures
• Judith Sheft, Executive Director, NJ CSIT
• Jorge Ramirez, Vice President, M&A and Business Development, Quest Diagnostics
• Rik Mehta, Cofounder and CEO of Lactiga US, Inc

Moderated by John Pennett, Partner, Life Sciences and Technology Group, Eisner Advisory Group LLC.

Sponsored by the New Jersey Economic Development Authority, Princeton Innovation Center BioLabs, and BioNJ.

Join our Platinum Sponsor Thermo Fisher Scientific for a Technology Showcase and engage in conversations with Thermo Fisher Scientific specialists in the following areas: 

1. Flow Cytometry
2. Recombinant Proteins
3. Cell and Gene Therapy
4. Luminex Biomarker Discovery and Validated Assays
5. Cell imaging and Analysis

And learn more about the latests innovations in cell therapy manufacturing. 

Lunch and refreshments will be served. Please RSVP by Monday, July 22, by scanning the QR code below. 

Flipping the innovation script, Princeton Innovation Center BioLabs and the New Jersey Economic Development Authority (NJEDA) will host an evening of networking and reverse pitches on Tuesday, June 25, from 5 pm to 7:15 pm at Princeton Innovation Center BioLabs, 303A College Road East, in Princeton, NJ. 

This is an opportunity to hear directly from investors who will take center stage with a reverse pitch approach, discussing their mission and what they are looking for in an early-stage life science and biotech entrepreneur. 

An invitation-only event, early-stage life sciences and biotech companies who are looking for funding and would like to attend, can fill out this form.

Investors who will be taking part include Activate Venture Partners, Delaware Crossing Investor Group, Foundation Venture Capital Group, Golden Seeds Angels, Mid Atlantic Bio Angels, Mission BioCapital, Pace Healthcare, SpringTide, and Tech Council Ventures.  

If you are an early- to mid-stage startup, this is a do not miss opportunity!  

Join us for a discussion on how proteomics is revolutionizing drug discovery!

The topic will be presented by Evotec’s Andreas Tebbe, Vice President Global Mass Spectrometry, and Carla Tameling, Vice President PanHunter. They will discuss how Evotec leverages efficient multi-omics data generation and purpose-built AI/ML-based BioInformatics to foster better clinical outcomes. 

A complimentary lunch will be served. The RSVP deadline is Wednesday, June 5.

Andreas Tebbe

Carla Tameling

Are you aware of the federal funding program that supports the commercialization efforts of biotech innovators? The Small Business Innovation Research (SBIR) program at the National Cancer Institute (NCI) provides up to $6.4 million in funding life science startups, with no strings attached. 

As part of the NCI’s engine of innovation to advancing novel cancer-related technologies from lab to market, the SBIR Development Center funds a diverse portfolio of small businesses that are developing technologies to prevent, diagnose, and treat cancer. 

To learn more, join NCI SBIR, Rutgers University Office for Research, and the NSF I-Corps Hub Northeast Region for an information session during a provided luncheon at Princeton Innovation Center BioLabs. 

Following introductory presentations from cohosting organizations, NCI SBIR Program Director Sarra Djemil will provide a detailed overview of funding opportunities, commercialization resources, and application advice that biotech researchers can use to move their projects forward. This presentation is appropriate for researchers who are considering forming a small business to translate their work and bring their ideas to life. Topics to be covered include:

• New and current funding opportunities
• Application tips and suggestions
• Commercialization resources for applicants and awardees

After the presentation, attendees will have a chance to participate in a Q&A with NCI STTR awardee Neil Goldstein and meet one-on-one in person with Program Director Sarra Djemil to discuss their cancer technology project and funding eligibility. To be considered for a one-on-one meeting, please reach out to Michelle Roemer-Schoen with a one-page technology summary or specific aims page on your technology by Monday, May 13. 

For questions about the event, please email Michelle Roemer-Schoen. We look forward to seeing you there! 

BioNJ’s BioPartnering Conference is the signature event bringing together innovators, investors, and bio-pharmaceutical industry executives to facilitate funding, collaboration, and ultimately improve Patient outcomes. Located in the heart of New Jersey, the Medicine Chest of the World, this is a unique opportunity for entrepreneurs to meet 1:1 with investors and industry representatives from top biopharmaceutical companies. 

Panelists with expertise in pharma, biotech, diagnostics, venture, and technical and laboratory services, will offer large and small company perspectives on working with value-added partners as well as buy-side and sell-side partnering approaches and business models.

This is a great opportunity to interact with experts who have hands-on experience putting together collaborations and creating agreements to advance products and technologies, and secure capital.

Featured panelists
• Peter Butch, partner, Fox Rothschild LLC
• Dr. Manjula Donepudi, vice president of business development, Evotec
• Dr. Michael Johnson, president, New Jersey Innovation Institute, and former CEO of Visikol Inc.
• Jorge Ramirez, vice president, M&A and business development, Quest Diagnostics

Moderator
• Vincent A. Smeraglia, Esq., executive director, New Ventures Office for Research, Rutgers University

This program is cosponsored by Princeton Innovation Center BioLabs and the NJEDA’s New Jersey Bioscience Center.

About this event

Welcome to Getting Your Startup Investor Ready! Join us for this informative event where you’ll learn what you need to be prepared to attract investors to your startup. The discussion will be around what early founders need to prepare so that when they start speaking with funders they have their ducks in a row. This will include things like understanding your financials, preparing your slides, researching funders, and having a clear understanding of your marketplace. There will be time for audience Q&A. Following the program will be ample time for networking. Don’t miss out on this opportunity to network with like-minded entrepreneurs to gain valuable insights. 

• John Pennett, Partner, EisnerAmper. John is partner-in-charge of the National Technology and Life Sciences Group at Eisner Advisory Group LLC. He is an active angel investor, and advises many startup companies on fundraising strategies. 

• Carolyn Myers, CEO and President, FendX Technologies. Carolyn is leading FendX, a public company working on pathogen repelling products to combat infections. She is an angel investor, and has been a strategy advisor for many early startups. 

This in-person event will take place from 5–7:30 pm at Bendheim House, 26 Prospect Avenue in Princeton. So mark your calendars and get ready to take your startup to the next level. Schedule

Registration Opens: 5 pm
Program Starts: 5:30 pm
Reception & Networking: 6:30–7:30 pm

Presented by the Princeton Entrepreneurship Council. Cohosts: EisnerAmper and Princeton Innovation Center BioLabs.

NSF I-Corps Info Session at Princeton Innovation Center BioLabs
Learn how to make real-world impact with your innovations by turning them into products/services that create value in the market. 

Details
Find out how you can transform your discovery or innovation into the basis of a successful startup or venture and earn an NSF grant of up to $3,000 through the NSF I-Corps Northeast Hub — join us for a Lunch & Learn at Princeton Innovation Center BioLabs.

Lunch will be served so please RSVP by Feb. 15.

Meet the instructors and learn about Propelus I-Corps at Princeton University, a four-session program that provides training, funding and resources to transform scientific and technological innovations into real-world products and services.

The National Science Foundation’s I-Corps program provides specialized training and grants to researchers interested in exploring the commercial viability of their ideas for products and businesses that are based on their own inventions, University intellectual property, or any STEM-related technology.

Who Should Attend:

 • Faculty, postdoctoral researchers, graduate students and undergraduates who are developing a scientific or technical discovery at any institution  in the Northeast. 
• Innovators from across the Northeast region looking to commercialize their technology.
• Startup founders in the region with a technology-based innovation looking to explore its commercial potential. 

Benefits:

• TRAINING: Learn about the I-Corps Lean LaunchPad approach to evaluating technologies through customer-discovery research
• FUNDING: Grants of up to $3,000 can be used to fund customer-discovery expenses such as travel to conferences & trade shows, patient advocacy groups, and LinkedIn Premium. 
• RESOURCES: Teams will receive mentorship from seasoned entrepreneurs and innovators. Teams can also access other programs offered by Hub-affiliated institutions.
• FOLLOW-ON OPPORTUNITIES: Upon completion, teams are eligible for the national NSF I-Corps Teams program which provides an intensive 7-week training course and a $50,000 grant.

Applications are open for Propelus I-Corps at Princeton University; the required sessions are as follows:

• Propelus I-Corps Princeton dates*: March 25, 27, April 3, 17, 2024 from 4:00–7:00 PM ET (Mon/Wed afternoon schedule)
• Application Deadline: March 4, 2024
*Required Office Hours scheduled once a week

Investors across the country and startups from New Jersey’s vibrant biotech and life sciences ecosystem will converge on Princeton Innovation Center BioLabs Thursday, October 26, from 9 am to 4 pm, for a day of pre-selected lightening pitches, a fireside chat and invite-only networking.

Interested in attending as an investor? If so, fill out the Eventbrite registration form. Password is PICBinvestor. 

New Jersey’s dynamic and growing life science ecosystem continues to increase with exciting new companies launching in our state. Come and hear from three biotech companies dedicated to growing within New Jersey.

Our panelists include key biotech leaders who will share their insights and experiences, discuss innovation, capital formation, managing for growth, and the strategic landscape in New Jersey.

Panel
• Sheila Kennedy, Vice President, Market Access and Marketing, LinusBio (Mount Sinai spinout)
• Dr. John Pena, Founder, SonderRX (Cornell Medical School spinout)
• Dr. Shahram Hejazi, Entrepreneurship Specialist, Lecturer, James Wei Visiting Professor in Entrepreneurship, Princeton University

Moderator
• Linda Brown, Director, Professional Societies & Associations, Global Medical Affairs, Bristol Myers Squibb

The New Jersey Economic Development Authority (NJEDA) is thrilled to present “Navigating the Current Life Sciences Investing Environment” at Princeton Innovation Center BioLabs on Tuesday, July 25, from 5–7 pm. This event will feature an engaging discussion from a distinguished panel of investors.

Kara Moore, sector lead for life sciences, will provide a brief overview of NJEDA programs to support this ecosystem. Lexie Demirali, senior venture officer for venture programs, will proceed to moderate an expert panel of investors who have their hands on the pulse of fundraising in life sciences as we get an insight into deals, trends, and challenges for 2023. This is an opportunity to receive perspective into the future direction and anticipated changes in life sciences and healthcare industries.

Key Talking Points:

• Fundraising Strategies: Discover effective techniques for attracting venture capital investment and capturing investors' attention.

• Investor Perspectives: Gain a deeper understanding of the investor’s mindset, criteria, and decision-making processes.

• Challenges and Solutions: Overcome common fundraising challenges and learn how to navigate due diligence and valuation negotiations.

Don't miss this unique chance to learn from investors, gain insider knowledge, and network opportunities. Whether you’re a startup founder or an aspiring entrepreneur, reserve your spot now for this must-attend event. NJEDA appreciates the support of BioNJ and Princeton Innovation Center BioLabs to strengthen the New Jersey life sciences ecosystem.

Panelist: Jim Gale, Founding Partner and Managing Director, Signet Healthcare Partners
Panelist: Squire Servance, Founder and Managing Partner, Syridex Bio
Panelist: Mark E. Kolb, Partner, Tech Council Ventures
Moderator: Lexie Demirali, Senior Venture Officer, Venture Programs, NJEDA

Back in person after three years, BioNJ’s BioPartnering Conference will bring together more than 500 life sciences executives, investors, academic collaborators and business development professionals for networking, a full week of 1:1 partnering, company and startup pitch presentations, exhibits and plenary sessions. Plus, a highly anticipated networking reception offers the perfect opportunity to connect with future partners and investors. 

Back in person after three years, BioNJ’s BioPartnering Conference will bring together more than 500 life sciences executives, investors, academic collaborators and business development professionals for networking, a full week of 1:1 partnering, company and startup pitch presentations, exhibits and plenary sessions. Plus, a highly anticipated networking reception offers the perfect opportunity to connect with future partners and investors. 

Applications are open until Friday, February 24, for company and startup pitch presentations. 

Back in person after three years, BioNJ’s BioPartnering Conference will bring together more than 500 life sciences executives, investors, academic collaborators and business development professionals for networking, a full week of 1:1 partnering, company and startup pitch presentations, exhibits and plenary sessions. Plus, a highly anticipated networking reception offers the perfect opportunity to connect with future partners and investors. 

Back in person after three years, BioNJ’s BioPartnering Conference will bring together more than 500 life sciences executives, investors, academic collaborators and business development professionals for networking, a full week of 1:1 partnering, company and startup pitch presentations, exhibits and plenary sessions. Plus, a highly anticipated networking reception offers the perfect opportunity to connect with future partners and investors. 

Back in person after three years, BioNJ’s BioPartnering Conference will bring together more than 500 life sciences executives, investors, academic collaborators and business development professionals for networking, a full week of 1:1 partnering, company and startup pitch presentations, exhibits and plenary sessions. Plus, a highly anticipated networking reception offers the perfect opportunity to connect with future partners and investors. 

Please attend in person if you are able, so that you can network and meet the panelists. A live stream option will be available for those who cannot join us.

Join us for the second of our Entrepreneur’s Journey series of practical discussion and tips. This event will be about the nuts and bolts of what you need in your pitch deck. Bring your questions. The panelists are from the Life Sciences, but many of the details are applicable to all industries. The event will be followed by a networking reception — all are welcome.

This event is sponsored by the Princeton Entrepreneurship Council, the Foundation Venture Capital Group LLC, and Princeton Innovation Center BioLabs. 

To request disability-related accommodations, please contact Neal Bituin at fbituin@princeton.edu no later than three working days prior to the event. 

You will have the opportunity to meet 1:1 with Mark Esposito preceding the start of the program. If you would like to be considered for a 1:1 meeting (there are four time slots available: 3:30 pm, 3:50 pm, 4:10 pm, 4:50 pm), please submit a short request that includes your name, your company name, your pitch deck, questions that you’d like to discuss with Mark, and the time that you can come to Anne-Marie Maman at amaman@princeton.edu by Monday, April 10 at 9 am EDT. 

Panelists
Mark Esposito, PhD, founder and vice president, KayoThera
Michael Wiley, vice president, Foundation Venture Capital Group LLC

Moderator
Anne-Marie Maman, executive director, Princeton Entrepreneurship Council

Join us to learn how to access NJ academic, federal and nonprofit core labs to accelerate your R&D through the New Jersey Commission on Science, Innovation and Technology (CSIT) voucher programs. 

The discussion will provide an overview of the CSIT Catalyst R&D Voucher Grant Program, current Voucher projects and other resources from CSIT and the New Jersey Economic Development Authority. 

There will be time for networking and Q&A during the event. 

Panelists are:
• Vincent A. Smeraglia, Esq., executive director, Rutgers University Biomedical Innovation Cores and executive director, University Core Facilities
• Alex Norman, executive director, Princeton Institute of Materials, Princeton University
• Irene Wei, PhD, MBA, founding CEO and president, CSR Pharma Group/ChemSun
• Nyron Khan, cofounder and CEO, Six Therapeutics Inc. 
• Frances Keel, program officer, New Jersey Commission on Science, Innovation and Technology
• Mahako Etta, program manager, New Jersey Commission on Science, Innovation and Technology (moderator)

Join us for the first of our Entrepreneur’s Journey series of practical discussions and tips. This event will be about the nuts and bolts of what you need to get ready to start raising funds for your startup. You will hear from both the founder and the funder side. Bring your questions. The panelists are from the Life Sciences, but many of the details are applicable to all industries. The event will be followed by a networking reception — all are welcome. 

Panelists are:

• Mark Esposito, PhD, founder and vice president, KayoThera
• Mike Wiley, vice president, Foundation Venture Capital Group LLC
• Merika Koday, PhD, principal, Accelerator Life Science Partners
• Anne-Marie Maman, executive director, Princeton Entrepreneurship Council, Princeton University

This event is sponsored by the Princeton Entrepreneurship Council, Princeton Innovation Center BioLabs, and the Foundation Venture Capital Group LLC.

Panel Discussion: “How to Build an Effective Company from Academics — How Is This Trend Reflected in NJ, and How Can It Be Accelerated?”

Boehringer Ingelheim Academy
Boehringer Ingelheim’s Grass Roots activities are centered around developing a personal relationship with the companies they work with. And their Academy sessions provide an informal opportunity for early-stage life science companies to network with other bio-entrepreneurs as well as hear from Boehringer Ingelheim business development, scientific and commercial leaders and some of their partners and key opinion leaders. 

There are many factors that are involved in building an effective company out of an idea from academia. There needs to be an assessment of the potential for impact, a business plan needs to be created, investors need to be found, as well as other considerations.

The topic for the Academy will focus on this life science startup trend out of academia in New Jersey and discuss ways to attempt to perform this successfully and in a potentially accelerated way. 

Panelists are:
• Scott DeWire, PhD, US Head of BD&L, Boehringer Ingelheim (moderator)
• Patrik Erlmann, PhD, US Head of Research Beyond Borders, Boehringer Ingelheim
•Zemer Gitai, PhD, Professor, Department of Molecular Biology, Princeton University
• Jim Gunton, Managing Partner, Tech Council Ventures, NJ
• Fei Shen, PhD, Managing Director, Boehringer Ingelheim Venture Fund USA, Inc. 

Don’t miss this opportunity to sign up for Boehringer Ingelheim’s in-person “Office Hours.” Follow the instructions above on how to apply; applications close on Friday, October 28.

Join LaunchBio at their next Founders Circle in Philadelphia. This small group session will focus on what differentiates a startup in this space seeking licensing opportunities and how to position you cell or gene therapy company for success. Hosted by BioLabs Philadelphia. Seating is limited; register today!

Learn practical ways to protect patient and research data from cybersecurity crime and the critical considerations essential to all life sciences-related businesses. Find out more here. 

Did you know?

• New Jersey tech and life science companies can be awarded up to $20M from New Jersey’s Net Operating Loss Program?
• New Jersey Angel Investor Tax Credit provides up to $35M in tax credit per calendar year to investors that invest in New Jersey companies?
• The $600M New Jersey Evergreen Innovation Fund launched this year to fund startups in New Jersey?
• There are also federal tax programs with a cash component that may be available to New Jersey’s R&D companies?

Join us on Thursday, October 20, from 5:00–6:30 p.m. to learn more about New Jersey’s funding and incentive programs and hear from New Jersey’s life sciences industry leaders who have benefited from these important incentive funding programs. 

Panelists are:

• Mehdi Javanmard, founder and CEO, RizLab Health, Inc.
• Kara Moore, senior advisor, Life Sciences, NJEDA
• John Pennett, partner, Eisner Advisory Group LLC (moderator)
• Judith Sheft, executive director, New Jersey Commission on Science, Innovation and Technology
• Mario Taglietti, MD, president, CEO and director, SCYNEXIS

Hosted by Princeton Innovation Center BioLabs and the NJEDA’s New Jersey Bioscience Center Incubator at North Brunswick. 

Venture capital investing requires a due diligence process.

What are “checklists” used by ventures to assess risk and opportunity? How are metrics weighted in decisions to proceed through diligence? What bottlenecks arise? What red flags can be overcome and what are walked away from? 

Join Part Two of BioLabs@NYULangone’s panel on fundraising, including a networking opportunity. 

Register today for BioNJ’s Twelfth Annual BioPartnering Conference, “The Future of Partnering: Evolving Opportunity Despite Uncertainty.” You’ll enjoy interactive plenary sessions, 1:1 partnering, company and pitch presentations, networking and more. Presenting companies range from early-startups to later stage companies and everything in between.

The schedule is as follows:

In-person Networking Reception: Monday, May 9, 2022
Virtual Conference: Tuesday, May 10, 2022 and Wednesday, May 11, 2022
Virtual 1:1 Partnering: Monday, May 9, 2022 through Friday, May 13, 2022

For more information, click here. 

Register today for BioNJ’s Twelfth Annual BioPartnering Conference, “The Future of Partnering: Evolving Opportunity Despite Uncertainty.” You’ll enjoy interactive plenary sessions, 1:1 partnering, company and pitch presentations, networking and more. Presenting companies range from early-startups to later stage companies and everything in between.

The schedule is as follows:

In-person Networking Reception: Monday, May 9, 2022
Virtual Conference: Tuesday, May 10, 2022 and Wednesday, May 11, 2022
Virtual 1:1 Partnering: Monday, May 9, 2022 through Friday, May 13, 2022

For more information, click here. 

The Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a critical source of non-dilutive financing for early-stage companies. The National Cancer Institute (NCI) SBIR Development Center provides funding, networking, and mentoring support for small business developing innovative cancer technologies. In fiscal year 2022, NCI SBIR will provide $182 million to small businesses to translate their innovation from lab to market. 

Join Princeton Innovation Center Biolabs, the National Cancer Institute (NCI) SBIR Development Center, the New Jersey Commission on Science, Innovation and Technology, and the Princeton Entrepreneurship Council, for a free program about funding opportunities available through the NCI SBIR Development Center. 

NCI SBIR Director Michael Weingarten and Program Director Monique Pond will discuss fundamental information on NCI SBIR/STTR funding, as well as commercialization resources and application tips. Judith Sheft, executive director of the New Jersey Commission on Science, Innovation and Technology, will moderate the event. 

You will learn about:

• SBIR/STTR eligibility requirements
•NIH SBIR/STTR process and new cancer-focused funding opportunities from NCI
• NCI SBIR/STTR initiatives such as the I-Corps at NIH Entrepreneurship Program, Applicant Assistant Program, etc. 
• NCI Investor Initiative to help NCI SBIR-funding companies to connect with investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries
• Practical strategies on how to successfully submit competitive research proposals

Fifteen minute 1:1 sessions are now being scheduled with NCI SBIR program directors. Attendees can schedule an appointment by sending a one-page technology summary along with your name and affiliation to Bryce Geiling (bryce.geiling@nih.gov), communications specialist, NCI SBIR Development Center. 

Panelists:

• Michael Weingarten is the director for the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute in Bethesda, Maryland. 

• Monique Pond is a program director in the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI). 

• Judith Sheft is the executive director of the New Jersey Commission of Science, Innovation and Technology. 

The due diligence process helps investors assess level of risk of their investment into your startup. However, investors have different levels of risk tolerance, experience, and areas of focus. So how is a founding team to tailor their diligence package to appeal to a broad set of investors?

Join BioLabs@NYULangone on Tuesday, April 19th from 4:00–5:30 p.m. as they explore due diligence requirements and preferences of a variety of investors so that teams can develop comprehensive strategies with wide relevance and appeal.

This is the first of a two-part series. Their next panel in the series will explore strategies to prepare for diligence performed by professional investors, such as VCs and Family Funds.

This event will be held virtually and there will be a short networking session following the panel, giving attendees a chance to speak with other members of the life sciences community.

Speakers:
• Benji Leibowitz, biotech investor at KdT Ventures
• Ana-Maria Visoiu, MPH, clinical & experimental sciences at Regeneron Pharmaceuticals, Inc.  

Raising a Series A round is a major milestone for a high-growth startup. To get there, you need to convince investors that you have a viable business model with strong growth potential.

Join us on Tuesday, March 29, from 12–1:30 p.m. EDT via Zoom. Our panel of experts will discuss what it takes to raise a successful Series A round, including how to know when it’s time to raise your first round, implications of raising capital, how long the process takes, and much more. 

Panelists:

Mark Esposito, CEO and cofounder of KayoThera, and principal at Meagi, a consultancy with expertise in preclinical therapeutic development

Kristina Fontanez, ­­­­­­vice president, biology at Fluent BioSciences, Inc. 

Fei Shin, managing director, Boehringer Ingelheim Venture Fund USA Inc.

Anthony Williams, new ventures associate, Office of Technology Licensing, Princeton University

This event is hosted by Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council. 

Many startups are undertaking projects across biotech and life sciences using algorithms built from massive private and public databases, including mapping genomic data, drug discovery, and optimizing clinical trial design. But who really owns this data and what can be done with it?

Join BioLabs@NYULangone for an in-depth discussion with a panel of experts examine the issues and ethical concerns surrounding data ownership and monetization. This panel will be followed by a short networking session, allowing for a chance to connect with their speakers and other members of the NYC life sciences community. 

Trade secrets are many companies’ most valuable intellectual property. They include formulas, specialized processes, proprietary algorithms that provide a competitive advantage, and confidential customer and pricing lists. 

But not all competitive information qualifies as a trade secret, and some information that would otherwise qualify may lose that status if not properly protected. Join Fox Rothschild attorneys Eric Reed and Brian Berkley as they cover the basics of trade secrets and how to effectively protect them, including:

• Examples of trade secrets and their values to companies
• What does and does not qualify as a trade secret?
• What practices improve trade secret protection?
• How to mitigate the risk that your trade3 secrets will be stolen
• How to ensure you don’t inadvertently take others’ trade secrets
• What to expect when a lawsuit is filed
• Risks of trade secrets litigation

You started a business and likely have a lawyer. But did you know that your approach to engaging a law firm can provide you with significant tools and insights to help you de-risk your enterprise, beyond just filing your patent and writing your agreements?

Join BioLabs@NYULangone to discuss the legal landscape available to biotech startups and how to leverage lawyers to drive your success and de-risk your endeavors at various stages of your startup.

Some of the topics being explored include:

• The impact of the type and location of a firm on the various development stages of a startup
• Developing a legal portfolio changing and adding law firms to represent and work for you
• Navigating conflicts of interests with your law firm
• How to start leveraging your law firm for partnerships, resources and risk capital
• Tips to manage legal bills (stet)

This event will be held virtually and a link will be sent out to registrants prior to the evening it occurs. There will be a short networking session to follow the panel, giving attendees a chance to speak with other members of the life sciences community. 

Vanguard technologies are democratizing access to healthcare and solving critically unmet needs. Hear from founders taking the most recent discoveries from the bench to the clinic for better diagnostic and therapeutic options. Speakers include:

• Harvey Tian, CEO of Inso Bio
• Mehdi Javanmard, CEO of RizLab Health (Princeton Innovation Center BioLabs resident company)
• David Bravo, CEO of Panel Therapeutics

The event will include startup pitches, a moderated discussion among panelists, and the opportunity to network with other attendees.

Join the Foundation for Health Advancement on Thursday, December 16 from 12–1:15 p.m. ET, for their next Innovate and Educate event. This event will not only expose STEM oriented graduate students and post-docs to the role venture capital may play in funding the inventions they are creating in their academic and research programs, but will also explain the types of jobs that may be available within the venture capital ecosystem for individuals that have a STEM background. The panel is made up of professionals that work in venture capital that also have PhDs in STEM oriented subjects. They will share their experiences in funding and supporting STEM oriented startup companies and share their experiences for how they navigated from PhD scientists to landing jobs in the venture capital industry. 

While this program is oriented towards higher-education STEM students and post-docs, it is open to all students or individuals that may be interested in accessing venture capital or finding a job in venture capital.

Moderated by Mike Wiley, vice president, Foundation Venture Capital Group. 

This free event will be held virtually via Zoom (link to be provided later to registrants).

Presented by the Foundation for Health Advancement, along with event partners Rutgers School of Graduate Studies iJobs and Princeton Innovation Center BioLabs.

Join us for a fireside chat on Monday, December 13, from 5–6 p.m., ET, featuring attorneys from Fox Rothschild’s Intellectual Property Law Department in Princeton, New Jersey. This free-ranging conversation, led by Gerry Norton, PhD, Nancy Halpern, DVM, Jimmy Hao, PhD, and Joe Chen, PhD, will address the legal, social, historical and policy aspects of the current COVID-19 pandemic. Moderated by Beth Rowley, director of operations, Princeton Innovation Center BioLabs. 

Can the choice of corporate structure make a difference in achieving your startup goals?

On December 7, at 5:00 p.m. ET, hear from unconventional founders Jen Horonjeff, CEO of public employee benefits cooperative Savvy Cooperative, and Ethan Perlstein, CEO of public benefit corporation Perlara, as they share their insights on building a successful bio company through thoughtful use of structure. 

We dive into how corporate structure relates to your mission, customers, staff, and funds. Immediately following the Q&A portion of the panel, you’ll have an opportunity to meet and talk with our speakers at virtual tables. 

Register below for this installment of our series on De-Risking Biotech and feel free to share with anyone interested in connecting with the NYC Life Sciences Community!

Investments in CleanTech are soaring, as is the number of startups in the space. If you are interested in the CleanTech industry, and you want to better understand how this fast-paced industry is changing, and how investors and innovators are preparing for that change, join us!

At the Engage 2021 Conference, on Thursday, December 2 at 11:15 a.m. ET, there will be a discussion exploring the trends that will drive CleanTech investments over the next few years. 

Pallavi Madakasira, director, clean energy at the New Jersey Economic Development Authority, will moderate a panel discussion featuring Thomas Erickson, managing partner at Imperative Ventures, and Vishal Shah, CEO and managing partner at Hydrogen Technology Ventures. 

Engage 2021, the second annual Princeton University innovation and entrepreneurship conference, is virtual, open to the public, and free to attend. 

Hosted by Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council.

Engage 2021, Princeton University’s annual innovation and entrepreneurship conference, will be held online December 1–2, 2021. This dynamic conference will bring together researchers, innovators, entrepreneurs, industry, government and innovation stakeholders to accelerate the impact of timely research and innovation. At Engage 2021, you'll discover industry intersections, entrepreneurship, transformational research and Princeton's leadership of the regional innovation ecosystem. All are welcome at Engage 2021 to: gain knowledge through skill-building, case studies and success stories; connect with a diverse group of accomplished professionals sharing experiences of discovery, collaboration and impact on the world’s most pressing issues; and accelerate the impact of emerging ideas and technologies. Hear from 100+ speakers who will share insights and opportunities arising from research in cancer, next-gen quantum computing, wireless technology, Net Zero and transportation, AI and bioengineering, and crypto – as well as offer tips and takeaways on topics ranging from venture capital to industry-academic collaboration to federal research support and startup accelerators. No Princeton affiliation is required.

Engage 2021, Princeton University’s annual innovation and entrepreneurship conference, will be held online December 1–2, 2021. This dynamic conference will bring together researchers, innovators, entrepreneurs, industry, government and innovation stakeholders to accelerate the impact of timely research and innovation. At Engage 2021, you'll discover industry intersections, entrepreneurship, transformational research and Princeton's leadership of the regional innovation ecosystem. All are welcome at Engage 2021 to: gain knowledge through skill-building, case studies and success stories; connect with a diverse group of accomplished professionals sharing experiences of discovery, collaboration and impact on the world’s most pressing issues; and accelerate the impact of emerging ideas and technologies. Hear from 100+ speakers who will share insights and opportunities arising from research in cancer, next-gen quantum computing, wireless technology, Net Zero and transportation, AI and bioengineering, and crypto – as well as offer tips and takeaways on topics ranging from venture capital to industry-academic collaboration to federal research support and startup accelerators. No Princeton affiliation is required.

Join BioLabs@NYULangone for a virtual panel discussion on Wednesday, October 27. 

Panelists include Rana Al-Hallaq, PhD, from Pfizer, David Blair, PhD, from Boehringer Ingelheim, Stephen Pitt, PhD, from Johnson & Johnson, and Jeffery Smith, PhD, from Bristol Myers Squibb. They will provide the perspective of some of the largest and most influential corporate business development and investment teams on how to attract and create partnerships between biotech startups and established corporations.

This event is in partnership with WCBA: Westchester County Biosciences Accelerator (The Catalyst), and ABCT: Accelerator for Biosciences in Connecticut.

According to the FemTech Landscape Report 2021, the women’s health market size is estimated to reach $60 billion by 2027 globally. 

As funders and founders have seen growing success in this market, and as the number of female funders has increased, the number of startups being funded and acquired has grown. Technology startups that address women’s health and wellness issues are found across a broad range of sectors including devices, treatments, software, consumer products, therapeutic drugs, and educational resources geared toward improving women’s lives. 

On Thursday, October 7, from 4 to 5:30 p.m. EDT, Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council will host a free panel discussion on “VC Insights—Trends and Opportunities in Women’s HealthTech.”

Join our panelists for a dynamic conversation as they share their views about the women’s health market, the trends that they see driving this market and the exciting opportunities that remain to be addressed by founders and funders alike. 

Laura Yecies, MBA, MSFS, is the CEO of Bone Health Technologies, maker of OsteoBoost, the first effective and safe non-drug treatment for low bone density. Previously she was CEO of SyncThink a medical diagnostic company, Catch, which she sold to Apple and SugarSync which was acquired by J2Global. She has been profiled in The New York Times and multiple periodicals and is a prolific speaker and writer on healthcare and technology. 

Karen Drexler, MBA, serves as an independent director for ResMed (NYSE), a market leading company in the disordered breathing space. She is also an independent director for Outset Medical (Nasdaq), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, where she also serves as compensation committee chair. She is a founding member of Astia Angels and an active member of the Life Science and Women’s Health Councils for Springboard. 

Over 30+ years, Linda Greub, CFA, MBA, has invested in public and private life science companies as an institutional investor, a corporate M&A executive, a hedge fund analyst, and a private venture investor. Her areas of expertise include finance, operations, and mergers and acquisitions and, within the life sciences specifically, diagnostics, genomics, healthcare services, and life sciences tools. In 2019, she cofounded Avestria Ventures, which invests in early-stage women’s health and female-led life science ventures. 

Moderator Nishta Rao, MBA, is currently managing director at First Republic Bank where she is responsible for the growth and expansion of the bank’s life science vertical. Prior to this, she was managing director at BioLabs@NYULangone where she supported the translation of technologies into commercially viable products and therapies. In addition, she also launched and led Princeton Innovation Center BioLabs. Rao, a molecular biologist by training, has scientific experience both in academia and industry. She also serves as a mentor to several startup companies in the life science and healthcare space.

Early-stage biotech has become increasingly attractive for large corporate biotech and pharma companies looking to gain a competitive edge by enhancing their development and pipeline portfolios. These partnerships have significant advantages for startups in terms of capital raises and leveraging deep corporate expertise to de-risk therapeutic developments startups are aiming to advance to market.

Join us for a conversation with Chandra Ghose-Paul, founder and CEO of BioHarmony. She will share her journey successfully closing a deal with a strategic partner. She will be joined by Brendan Rae, vice president licensing and business development at Qilu Pharmaceuticals, who helps startups and institutions navigate such deals. The event will take place virtually, on the Airmeet platform. 

Feel free to send questions for the speaker to madeleine@designtechnologiesllc.com by September 28 9 p.m. EDT. Additional questions will be accepted during the session as time permits. 

The panel will be followed by a brief networking session, offering attendees a chance to connect with other members of the New York life sciences and biotech community. 

Aiming to broaden opportunities for university innovators who are underrepresented in entrepreneurship, Princeton University will host Empower 2021: A Virtual Conference Celebrating Black Academic Entrepreneurship on Sept. 23–24.

This is the first in an annual conference series that will support entrepreneurs in academia from different historically underrepresented groups. Empower 2021 will bring together national thought-leaders to share actionable knowledge and tools that can help transform university discoveries into companies and ventures that advance societal and economic progress.

The two-day conference will also feature a pitch competition with a $100,000 top cash prize. In addition, the winning entrepreneurs will receive a bundle of in-kind services, one-to-one meetings with select venture capital firms, and expert mentoring and coaching.

The 2021 event highlights and celebrates Black academic entrepreneurs from universities around the U.S. and beyond. All people, groups and organizations supportive of inclusive innovation are encouraged to attend. Faculty, professional and postdoctoral researchers and graduate students will be able to build networks with industry and venture capital representatives and explore ways to start, fund and scale new startups.

Empower 2021 is sponsored by Princeton University, Mastercard Center for Inclusive Growth, Mintz, and the National Urban League.

Attendance is virtual and free.

Aiming to broaden opportunities for university innovators who are underrepresented in entrepreneurship, Princeton University will host Empower 2021: A Virtual Conference Celebrating Black Academic Entrepreneurship on Sept. 23–24.

This is the first in an annual conference series that will support entrepreneurs in academia from different historically underrepresented groups. Empower 2021 will bring together national thought-leaders to share actionable knowledge and tools that can help transform university discoveries into companies and ventures that advance societal and economic progress.

The two-day conference will also feature a pitch competition with a $100,000 top cash prize. In addition, the winning entrepreneurs will receive a bundle of in-kind services, one-to-one meetings with select venture capital firms, and expert mentoring and coaching.

The 2021 event highlights and celebrates Black academic entrepreneurs from universities around the U.S. and beyond. All people, groups and organizations supportive of inclusive innovation are encouraged to attend. Faculty, professional and postdoctoral researchers and graduate students will be able to build networks with industry and venture capital representatives and explore ways to start, fund and scale new startups.

Empower 2021 is sponsored by Princeton University, Mastercard Center for Inclusive Growth, Mintz, and the National Urban League.

Attendance is virtual and free.

Join BioLabs@NYULangone and Design Technologies on Tuesday, August 31, at 5 pm EDT for a virtual event on how to de-risk your capital raising venture. 

Capital fundraising in biosciences is a red-hot pursuit in this time of soaring liquidity—but is not without its challenges and risks. So, is crowdfunding a viable de-risk strategy for raising capital?

A New York orthopedic surgeon and a CFA, cofounders of Monogram Orthopedics, raised $14.5 million in a Reg A filing, the largest amount raised for a medical device in crowdfunding history. Hear the founders and fundraising team tell their story and lay out the pros and cons of crowdfunding in this groundbreaking approach.

Thinking about life sciences entrepreneurship but aren’t sure how to make the transition or what the job would look like?

Come hear from the IndieBio team and alumni about a four-month program to turn science into products, build scalable businesses, raise investment, and develop the leaders of tomorrow!

Join us for a free virtual info session to learn more about IndieBio and opportunities for PhD students and postdocs. 

This event is cosponsored by Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council. 

Registration is a must.

Register today for BioNJ’s 11th Annual BioPartnering Conference where they’ll bring together life sciences leaders, investors, institutions and business development professionals from the Northeast and beyond.

Register today for BioNJ’s 11th Annual BioPartnering Conference where they’ll bring together life sciences leaders, investors, institutions and business development professionals from the Northeast and beyond.

The disruptions and opportunities created by a new generation of digital healthcare innovations will lead to winners and losers, and a changed landscape for patients, practitioners and others throughout the healthcare ecosystem. While COVID-19 has accelerated this digital transformation, the pace of change will continue well into the future.

Join our panelists for a dynamic conversation on the trends that are disrupting healthcare as we know it and shaping the future of global health.

Dr. Jean Drouin is a leader with over 25 years of experience in healthcare management, technology, operations, finance, and cultural change. As CEO and founder of Clarify Health Solutions, Jean focuses on creating the environment that allows Clarify to deliver on its mission by delighting customers and growing a great team. Prior to founding Clarify, he was a senior partner at McKinsey, where he led the healthcare digital and IT practice. He also built and served as the founding head of McKinsey Advanced Healthcare Analytics (MAHA), which provided services and products on healthcare reform, consumer analytics, new payment and pricing models, and risk management.

Dr. Shahram Hejazi is a life science investor and entrepreneur with general management experience in both early-stage ventures and large global companies. As a partner with BioAdvance, he is responsible for investments in research tools, devices, diagnostics and health IT. He is also the chairman of the Pediatric Device Consortium fund at the Children’s Hospital of Philadephia. Shahram is the 2014 James Wei Visiting Professor of Entrepreneurship at Princeton University where he is currently a part-time faculty.

Dr. Kimberly Newell Green is a pediatrician and associate clinical professor at the University of California San Francisco and past president of the San Francisco Marin Medical Society. She is the former chief of healthcare Innovation at Kaiser Permanente in San Francisco where she worked as a general pediatrician for over a decade. She is working to transform healthcare by leading and supporting innovations in digital technology while keeping humanity at the center of health and healing.

Dr. Carolyn Bradner Jasik is a board-certified clinical informatics physician with 15+ years of experience in digital health technology. She has held executive leadership roles in hospital administration, academic medicine, and industry. At Omada Health she serves as chief medical officer and oversees the delivery of chronic disease programming that has served 500,000+ patients for 1500+ customers. She has a strong track record of publishing on digital health both in academic and industry. Carolyn continues to practice at UCSF where she is an associate professor of pediatrics.

This event is hosted by Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council. 

Join the Foundation for Health Advancement for “Startup Investing and the Outlook for 2021.” Part of their Innovate and Impact Series, this free event will cover how investors are supporting existing portfolio companies, evaluating new investments in a virtual environment, opportunities currently of interest, and new and accelerated business opportunities that may survive post-pandemic. Click here for more information.

Princeton Innovation Center BioLabs is pleased to bring to the Central New Jersey community, and others, the opportunity to learn about different accelerators for early-stage startups in all industries.

MassChallenge is the global network for innovators. They support entrepreneurs and their startups through the early stages of building a business. 

Founded in 2009, MassChallenge’s mission is to equip bold entrepreneurs to disrupt the status quo and create meaningful change. 

Through their nonprofit, zero equity accelerator model they support more than 400 startups a year, from all industries and anywhere in the world, across 7 locations and 9 programs.

MassChallenge accelerators are the most efficient pathway to connect startups, experts, corporations, and communities to grow and transform businesses and economies. 

At this event, founders will learn what’s in store for the 2021 program and what it takes to apply.

If you’re interested in participating in the 2021 startup cohort, don’t wait for the event, apply here.

You will receive a Zoom link prior to the start of the event.

Following the Info Session, Office Hours will be available from 1–3 p.m. with MassChallenge’s Senior Director of Partnerships, Will Magruder. Interested applicants can schedule a 1:1 15-minute session here.

Cohosted by Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council.

Come hear from the IndieBio team and an alumnus about a four-month program to turn science into products, build scalable businesses, raise investment, and develop the leaders of tomorrow!

Join us for a free virtual info session to learn more about IndieBio and opportunities for PhD students and postdocs.

This event is cosponsored by Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council.

Registration is a must. To join the webinar, click on the URL included in the email confirmation.

Join us, along with our partner the Foundation for Health Advancement for a free event, “Navigating the Path to Startup Success.” Hear from founders and their investors who will share their lessons learned and successful steps in taking an idea from conceptual development through commercial launch, growth and eventual exit.

Panelists 
• John Frankel, founding partner, ff Venture Capital
• James M. Golubieski, president, Foundation Venture Capital Group
• Dr. Michael Johnson, CEO & cofounder, Visikol 
• Brian Mulhall, entrepreneur & angel investor
• Ari Rabban, CEO & cofounder, Phone.com

The Foundation for Health Advancement (FHA) is a 501C(3) not-for-profit organization. FHA’s programs grow new science-based businesses in collaboration with New Jersey-based research institutions and inspire students to pursue STEM majors and careers. FHA, in partnership with its affiliates, New Jersey Health Foundation (NJHF) and Foundation Venture Capital Group (FVCG), provides funding and technical support to faculty and student researchers at six New Jersey-based research institutions: Kessler Foundation, NJIT, Princeton University, Rowan University, Rutgers University and Stevens Institute of Technology. 

The life sciences industry ecosystem is as robust as ever. Early-stage capital has trended upward for several years, while larger venture capital funding for healthcare has set record highs. According to JPMorgan Chase & Co., “Funding raised by venture capitalists in healthcare and life sciences in the first half of this year may be on pace to surpass those raised in 2018 and 2019.”

Join us for a fireside chat with Dr. Dora Mitchell and Dr. David Tukey as they discuss “Current Trends in Life Sciences Funding.”

Mitchell is an entrepreneurial life science leader, with 20 years of experience across research, venture capital, academic incubation and technology transfer, and the building of young life science companies.

Tukey is a healthcare investor at Point72 Asset Management, a multi-strategy investment firm with >$17b under management.

Cohosted by Princeton Innovation Center BioLabs and the Princeton Entrepreneurship Council, this event is part of Princeton University’s Engage 2020, a three-day inaugural innovation and entrepreneurship conference live and online, November 4–6. You must register for the conference to attend the fireside chat.

For questions, please contact either Michelle Roemer-Schoen, events manager, Princeton Innovation Center BioLabs, or Lauren Bender, program manager, Princeton Entrepreneurship Council.

A free, multiday virtual conference focusing on innovation and entrepreneurship

In this three-day, immersive event, you’ll:

• Create your own agenda from more than 50 virtual sessions of relevance to academia, business and industry, Princeton University alumni, entrepreneurs, investors, foundations and the intellectually curious
• Hear from Princeton’s academics, inventors and entrepreneurs in fields such as energy and sustainability, bioengineering, art and architecture, and social impact
• Visit exhibits about Princeton-related innovations and startup companies, New Jersey scientific research facilities, and Princeton Innovation campus partners
• Connect with other attendees

A featured program track for the entrepreneurially-minded: A robust slate of webinars, skill-building workshops and Princeton-related startup showcases will offer entrepreneurs and those who work with them an abundance of thought-provoking opportunities.

For more information, visit Engage 2020 on the Princeton Innovation website or contact Anne-Marie Maman ’84, PEC Executive Director.

A free, multiday virtual conference focusing on innovation and entrepreneurship

In this three-day, immersive event, you’ll:

• Create your own agenda from more than 50 virtual sessions of relevance to academia, business and industry, Princeton University alumni, entrepreneurs, investors, foundations and the intellectually curious
• Hear from Princeton’s academics, inventors and entrepreneurs in fields such as energy and sustainability, bioengineering, art and architecture, and social impact
• Visit exhibits about Princeton-related innovations and startup companies, New Jersey scientific research facilities, and Princeton Innovation campus partners
• Connect with other attendees

For more information, visit Engage 2020 on the Princeton Innovation website or contact Anne-Marie Maman ’84, PEC Executive Director.

A free, multiday virtual conference focusing on innovation and entrepreneurship 

In this three-day, immersive event, you’ll:

• Create your own agenda from more than 50 virtual sessions of relevance to academia, business and industry, Princeton University alumni, entrepreneurs, investors, foundations and the intellectually curious
• Hear from Princeton’s academics, inventors and entrepreneurs in fields such as energy and sustainability, bioengineering, art and architecture, and social impact
• Visit exhibits about Princeton-related innovations and startup companies, New Jersey scientific research facilities, and Princeton Innovation campus partners
• Connect with other attendees

A featured program track for the entrepreneurially-minded: A robust slate of webinars, skill-building workshops and Princeton-related startup showcases will offer entrepreneurs and those who work with them an abundance of thought-provoking opportunities.

For more information, visit Engage 2020 on the Princeton Innovation website or contact Anne-Marie Maman ’84, PEC Executive Director.

From the safety of your home, join BioNJ’s Virtual BioPartnering Conference.

• Connect with life sciences executives, investors, institution collaborators and business development professionals

• Pre-schedule 1:1 meetings to discuss potential partnerships

• Watch company and startup pitch presentations 

• Hear from experts on industry trends and expectations, capital strategies and investor perspectives during plenary sessions

• Chat with exhibitors that can support your organization’s needs

• Discuss business and research opportunities with world-renowned institutions

More information is available here.

From the safety of your home, join BioNJ’s Virtual BioPartnering Conference.

• Connect with life sciences executives, investors, institution collaborators and business development professionals

• Pre-schedule 1:1 meetings to discuss potential partnerships

• Watch company and startup pitch presentations (application submission deadline 7/31/2020)

• Hear from experts on industry trends and expectations, capital strategies and investor perspectives during plenary sessions

• Chat with exhibitors that can support your organization’s needs

• Discuss business and research opportunities with world-renowned institutions 

More information is available here.

The Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a critical source of non-dilutive financing for early-stage companies. The National Cancer Institute (NCI) SBIR Development Center provides funding, networking, and mentoring support for small businesses developing innovative cancer technologies. In fiscal year 2020, NCI SBIR will provide $179 million to small businesses to translate their innovation from lab to market.

Join Princeton Innovation Center BioLabs, the National Cancer Institute (NCI) SBIR Development Center, the New Jersey Commission on Science, Innovation and Technology, and the Princeton Entrepreneurship Council, for a free program about funding opportunities available through the NCI SBIR Development Center.

NCI SBIR Program Directors Christie Canaria and Jonathan Franca-Koh will discuss fundamental information on NCI SBIR/STTR funding, as well as commercialization resources and application tips. Judith Sheft, executive director of the New Jersey Commission on Science, Innovation and Technology, will moderate the event.

You will learn about:

You will have the opportunity to meet 1:1 with program directors at the conclusion of the program. More information about the 1:1’s and registration will be sent closer to the date.

Join Mark E. Tabakman, a partner in Fox’s Labor & Employment Department, for a free webinar, hosted in conjunction with Princeton Innovation Center BioLabs, highlighting wage-hour and Fair Labor Standards Act issues related to and stemming from the COVID-19 pandemic.

Topics include:
• Rigorous new statutory developments/trends
• Recent relevant laws in New Jersey and New York
• Independent contractor: the landscape shrinks further
• USDOL taking a more business-friendly approach: new opinion letters

The coronavirus pandemic has presented corporate compliance professionals with unprecedented issues affecting disclosures, filings and other SEC requirements, and the second quarter deadline for Form 10-Qs is rapidly approaching.

Join Fox attorney Jesse Fishman for a free webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on the critical points of the SEC’s guidance regarding companies’ 10-Q and other periodic filings.

Topics include:
• SEC guidance contained in CF Disclosure Guidance Topic #9 and its impact on forward-looking statements, MD&A and disclosure controls and procedures
• Filing an extension for additional time to file your Form 10-Q, 10-K and certain other periodic reports
• Can companies engage in stock buybacks?
• Is it necessary to disclose if your CEO or other officers have COVID-19?
• Effects on periodic reports, proxy statements and other information that needs to be disclosed by companies
• Virtual shareholder meetings 

Join Fox Intellectual Property partners Shahnam Sharareh, PharmD, RAC, and Wansheng Jerry Liu, PhD, for a webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on intellectual property rights at issue in clinical trial agreements. They will also include perspectives from sponsors and research sites to help attendees learn to negotiate IP provisions of clinical trials agreements.

A number of groups have launched initiatives to address challenges associated with sharing intellectual property and knowledge in the fight against COVID-19, including the Open COVID Pledge, the World Health Organization’s patent pool and others.

Join Fox IP attorneys Chipo M. Jolibois and Gunjan Agarwal for a free webinar, hosted in conjunction with Princeton Innovation Center BioLabs, reviewing the initiatives and exploring issues entities should consider before participating in such programs.

Companies that have been affected by COVID-19-related business disruptions may resort to litigation to recoup losses. Join Fox partner Jeffrey M. Pollock for a webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on business interruption, property damage and other potential lines of insurance policyholders should consider when attempting to recover from financial harm caused by the pandemic.

Topics include:
• Detailing lines of coverage at issue
• Providing notice
• Documenting claims
• Obtaining appropriate coverage

Research institutes and pharmaceutical companies developing urgently needed medicines, vaccines and diagnostics to address the global pandemic caused by SARS-CoV-2 must streamline the research and discovery, regulatory approval and commercialization processes. This is true whether they are developing novel treatments or repurposing existing ones.

Join Fox Intellectual Property attorneys Gerard P. Norton, PhD, Jianming Jimmy Hao, PhD, and Nancy Halpern, DVM, and patent agent Joe Chen, PhD, for a webinar, hosted in conjunction with Princeton Innovation Center BioLabs, focused on COVID-19 precautions, testing and therapeutics, including anti-viral medicines and vaccines.

Featuring ten companies working on COVID-19 research, as well as, Phyllis Arthur, vice president of infectious diseases & diagnostics policy for BIO, who will discuss the industry’s response to this global pandemic, including more than 400 research programs for a virus that had not been identified until just a few short months ago!

Registration for members is $55 and $95 for future members.

For many companies struggling to maintain financial well-being in the midst of the COVID-19 pandemic, seeking the protections of bankruptcy court may be the best option to remain viable.

Join Fox Financial Restructuring & Bankruptcy attorneys Ray Lyons and Catherine Youngman for a webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on bankruptcy basics, intellectual property in bankruptcy, the Paycheck Protection Program and alternatives to bankruptcy.  

Join Fox Litigation partner Elizabeth Hampton for a webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on the basics of the litigation process, including:

• How to avoid litigation
• What to do if you are a defendant or a witness
• Tips on determining when to bring a lawsuit
• Noncompete clauses and confidentiality agreements

In light of the current COVID-19 crisis, the webinar will also address business interruption insurance, force majeure clauses and best practices for litigation risk mitigation. 

Even in these unprecedented times, merger and acquisition opportunities exist for companies seeking to expand their platform or enhance  their current and future value.

Join Fox Rothschild’s Michael Weiner for an informative webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on why companies may look to a merger or acquisition to create liquidity for sellers (and their investors) or to drive growth for buyers, as well as how that process can be implemented. 

As places of employment begin to reopen, it will not be business as usual due to concerns around COVID-19. Join Fox Labor & Employment attorneys Jonathan Ash and Lucy Li for an informative webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on the proactive steps companies can take to prepare to reopen safely and productively. 

Topic will include: 
• Updating existing policies and drafting new ones to address COVID-19 safety protocols
• Abiding by OSHA/CDC guidelines for ensuring a safe workplace
• Reviewing EEOC requirements
• Addressing employment terms and conditions and employee concerns (refusals to return, accommodations, FFCRA)

Questions? Contact Stephanie Forchi, events coordinator, at SForchi@foxrothschild.com.

Triumvirate Environmental’s EHS Regulatory Summit is packed with educational content for environmental, health, and safety (EHS) professionals. This free event provides a comprehensive look at EHS regulatory compliance and offers practical solutions to the challenges that industry professionals face today.

Speakers 

Mike Maffuccio, EHS Practice Director, Triumvirate Environmental – “EHS Regulations for Life Science Companies” 

Michelle Coutu Fluck, EHS Manager, Triumvirate Environmental – “Building a Culture of Safety”  

Aimee Giovine, EHS Manager, Triumvirate Environmental – “How Your Regulatory Requirements Change as You Grow From a Start-Up”  

Mark Liffers, EHS Practice Director, Triumvirate Environmental – “Basic Fundamentals of Biosafety and Radiation Safety for the BSL1 and BSL2 Laboratory”

A Wine Tasting Happy Hour will follow at 4:15 p.m. 

View the full agenda.

Join FBI and industry experts for an overview of trends, risk analysis and tactical precautions you can take to protect your organization from data breaches. Targeted specifically for startup to mid-size life sciences R&D and service provider organizations, the morning’s discussion will focus on:

• Insurance and liability considerations
• Criteria for assessing preparedness and risk tolerance
• Determining funding and resource requirements

View the full agenda.

Registration is $60 for BioNJ Members and $85 for Future Members. Contact Kim Minton at KMinton@BioNJ.org or 609-890-3185 to learn about Sponsorship opportunities.

Take the change to support entrepreneurs, meet early-stage startups, or get inspired by the judges’ feedback. Participants will have five minutes to pitch and two minutes to answer questions from the judges. This year’s competition will host startups from many different industries from food tech to health tech to green tech. The prize is a heavily subsidized booth at StartupGrind Global 2020.

Judges
E. Patrice Perkins, chapter director, Startup Grind Albany
Stephen C. Snyder, executive-in-residence, Princeton University
Karin Wolok, community curator and entrepreneur
Sheri Kurdakul, founder and CEO, VictimsVoice

Join us to watch the pitch competition. The event is free, but seating is limited. Application submissions are no longer being accepted. 

Though death and taxes are certainties of life, they can lead to contention when families fail to properly plan for them.

Join Fox Rothschild for a complimentary breakfast program where a trio of firm attorneys will outline estate planning considerations that can help prevent litigation.

Topics
• Overview of commonly litigated estate issues
• Family situations that often give rise to litigation
• Establishing, implementing and communicating an estate plan

New Jersey Founders & Funders enables early-stage businesses to meet with potential investors in 10-minute, one-on-one “speed dating” sessions to discuss strategy, business models, and funding opportunities. Each participating entrepreneur meets an average of six investors in curated one-on-one meetings during the event. Follow-up responses from attendees at the November 2018 New Jersey Founders & Funders event indicated that over 90 percent of those participants secured additional meetings with at least one investor. Entrepreneurs interested in participating in New Jersey Founders & Funders can apply online. Participation is a on a first-come-first-served basis.

Sponsored by the NJEDA Technology and Life Sciences team.

Patents are probably the most valuable assets for early stage biotechnology/life science companies. Oftentimes, patents are the only assets of such companies. 

Join Fox Rothschild for breakfast and a complimentary program presented by two of their patent attorneys, who will detail the essentials of patenting biologics. The presentation will cover the wide range of legal requirements, including a discussion of actual cases and review of best practices. 

Topics
• Patent essentials that a company needs to know
• Legal requirements for obtaining a patent on biologics, using real-world cases as examples
• Common IP-related mistakes made by early stage companies

Speakers
Gerard P. Norton, PhD, Partner, Intellectual Property
Jianming Jimmy Hao, PhD, Partner, Intellectual Property

Agenda
Registration & Breakfast: 8:30–9:00 a.m.
Presentation & Q&A: 9:00–10:30 a.m.

Registration Deadline
November 1

Questions? Contact 1.877.778.7369 or events@foxrothschild.com.

A significant milestone in an emerging company’s development timeline is the receipt and negotiation of a term sheet for an initial round of funding.

Join Fox Rothschild for breakfast and a complimentary program presented by two of their corporate attorneys, who will detail the basics on core terms and conditions of a transaction structure, as well as related economics and corporate governance provisions.

Topics
• Elements of a typical Series A term sheet
• Possible negational areas
• Alternative approaches for companies and investors 

Speakers
Vincent A. Vietti, Fox Rothschild LLP 
Michael P. Weiner, Fox Rothschild LLP 

Agenda

Registration & Breakfast: 8:30–9:00 a.m.
Presentation & Q&A: 9:00–10:30 a.m. 

Registration Deadline
October 27 

Questions? Contact 1.877.778.7369 or events@foxrothschild.com. 

If you are a business owner or inventor, you need to protect your intellectual property (IP). Attend this free one-day United States Patent and Trademark Office (USPTO) event and learn from government experts, IP attorneys, and local businesspeople about how U.S. rights holders can protect their IP in China. Space is limited; learn more and register early. 

Don’t miss this opportunity to gain valuable insights about:

• What you need to know about protecting your patents, copyrights, trademarks, and trade secrets in China, particularly for small- and medium-sized businesses
• Where is China going with IP?
• Enforcing IP rights in the United States
• U.S. government resources for U.S. companies 
• IP in China: the New Jersey experience

Continuing legal education (CLE) accreditation pending approval by the New Jersey State Bar Association. 

This event is one of a series of China IP Road Shows the USPTO is conducting across the country. It has been organized in cooperation with the U.S. Commercial Service Central/Southern New Jersey, Princeton University Corporate Engagement and Foundation Relations, and the Mid-Atlantic District Export Council.    

Agenda
A detailed agenda will be posted here at least one week prior to the event. 

Additional Information
The registration page provides additional information and directions. For non-press inquiries, contact nadine.herbert@uspto.gov at the USPTO’s Office of Policy and International Affairs.

Deer Isle Group CEO and President, Dianna Raedle, will host a free workshop where she will present best practices for raising capital from venture capital funds and other institutions. She will walk through some concrete examples of how companies should think about positioning themselves. This will be an interactive session where participants will be encouraged to share their own entrepreneurial experiences in order to provide real examples of the concepts.

Deer Isle Group, founded in 2007 and raised over $5 billion in capital since founding, is an innovative investment bank that focuses on helping Venture Capital companies raise capital. The Deer Isle Group uses a proprietary technology solution that enables companies to turbo-charge their own capital raise by accessing a curated relevant set of institutional investors that invest in seed, early stage, and Series A investments from a universe of over 10,000. In addition, Deer Isle provides investment banking and capital markets advisory.

Schedule 
Networking: 5:30 p.m.
Workshop: 6:00 p.m.

Hosted by Princeton Entrepreneurship Council. 

TechLaunch BullPen is designed for seasoned, early-stage tech entrepreneurs to present their budding enterprises to a panel of investors, members of the tech ecosystem and business community. The audience has a chance to hear, question, network, and interact with investors, presenters, and panelists alike.  

Valuable in-kind services are also awarded to the presenting company who the investor panel feels is the most fundable moving forward. The investor panel award is worth $15,000 in professional in-kind services from the sponsors of BullPen, including Withum, Gibbons Law, Gearhart Law, and Casabona Ventures.

• Network with other entrepreneurs & investors
• Hear live feedback to presenting startups
• Witnessing a mentored and vetted investor pitch
• Participating in the interaction between startups & investors

Take your STEM career to the next level and experience the power of helping women.

Join Fox Rothschild LLP and Princeton Innovation Center BioLabs for a day of inspiration, education and networking. Attendees will develop new connections and leave with valuable takeaways, including best practices, tools and strategies for career advancement.

Topics include:
• Populating the Pipeline: Challenges & Solutions for Women in STEM
• Together We Rise: Achieving Collective Success
• At the Pinnacle of Success: Tales from STEM Innovators

View the full agenda. There is no charge to attend the event.

Online registration is now closed. To register, email events@foxrothschild.com. 

Questions? Contact 1.877.778.7369 or events@foxrothschild.com.

Developed with J.P. Morgan and Johnson & Johnson Innovation, BioNJ’s Ninth Annual BioPartnering Conference will bring together more than 400 regional biopharmaceutical executives, investors, academic collaborators and business development professionals from the Northeast to Mid-Atlantic states for a day of networking, 1:1 partnering meetings, company presentations, exhibits and plenary sessions.

Apply today to be a company presenter and showcase your innovations to investors and business development professionals looking for new collaborations and partnerships. Limited slots available. There is no fee to apply or present. Deadline: March 27

Register by March 27 for the Early Bird Rate of $275 for BioNJ Members and $325 for Future Members. After March 27, the price will be $350 for BioNJ Members and $395 for Future Members. Contact Samantha Bamberger at 609.890.3185 or BioPartnering@BioNJ.org with questions.

More information >>>

Princeton Innovation Center BioLabs is proud to be a supporting partner of the BioNJ BioPartnering Conference.

Learn from an industry veteran on how to channel innovative science into novel medicines.

Princeton Innovation Center BioLabs and global pharmaceutical company Bristol-Myers Squibb (BMS) invite you to attend an exclusive speaking event featuring Dr. Miguel Sanjuan.

About Dr. Miguel Sanjuan
Dr. Miguel Sanjuan is a group director in the BMS Immuno-Oncology Small Molecule Biology Department. At BMS, Dr. Sanjuan leads a team of world-class immunologists with a proven record of discovering cancer treatments. Prior to joining BMS in 2017, Dr. Sanjuan worked at Medimmune (AstraZeneca) for eight years, where he led a team of twenty innovative scientists focused on the discovery of novel molecules for the treatment of autoimmune disorders. Previously, he worked as a staff scientist at St. Jude Children’s Research Hospital, where he discovered a novel intracellular mechanism that linked for the first time the cellular self-digestion pathway, autophagy, with the elimination of extracellular pathogens. His cutting-edge research has collectively led to peer-reviewed publications, in journals such as Nature, Nature Immunology, Immunity, and the Proceedings of National Academy of Sciences, USA (PNAS).

Dr. Sanjuan received a bachelor’s degree in biology from the University of Seville and a doctorate in molecular biology from the Autonomous University of Madrid. He then trained as a postdoc fellow at Johnson & Johnson.

Schedule
Networking: 5:30–6 p.m.
Presentation: 6 p.m.

Join us for a lunch presentation on insurance for emerging businesses courtesy of CBIZ, Inc., one of the nation’s leading providers of professional advisory services. Startups will learn

• common exposures for startups
• potential insurance solutions
• when and why specific coverages are needed
• what Directors and Officers Liability Insurance is and its importance

RSVP to Michelle Roemer-Schoen no later than Friday, April 12. 

Dr. Young-Jack Lee, president and founder of LSK Global, South Korea’s largest local contract research organization (CRO), will present a Lunch & Learn hosted by Princeton Innovation Center BioLabs and Fox Rothschild LLP.

Dr. In-Jin Jang, director at the Clinical Trials Center of Seoul University Hospital, one of the leading clinical trial centers in the world, will join Dr. Lee for the discussion. 

Lee and Jang will discuss the state of clinical trials and drug sponsorship in east Asia and the United States, including the unique opportunities available for drug sponsors and CROs who are able to leverage the benefits of efficient management of cross-border clinical trials. They will discuss and welcome questions on the state of Korean clinical trials in both the United States and Korea, informed by Dr. Lee’s experience working at the National Institutes of Health and the National Cancer Institute, both based in Bethesda, Maryland.

The presentation will also discuss the importance of building relationships between Korea and the U.S., which in turn improves the efficiency of the regulatory approval process for clinical trials.

The Lunch & Learn is ideal for universities, pharmaceutical and medical device clients, contract research organizations, investors and venture capital groups, anyone involved in work related to clinical trials and associated research.

Pictured: Dr. Young-Jack Lee

Jim Gunton, managing partner and founder of Tech Council Ventures, an early stage venture capital investment firm, will speak on the topic of networked capital. 

He has invested in privately-held growth technology companies for more than twenty years. Before cofounding in 2001 the $80 million NJTC Venture Fund, Gunton was a partner at Edison Venture Fund and a manager at Oracle Corporation in the Silicon Valley. He served formerly as a governor of the National Association of Small Business Investment Companies. He has served on the board of numerous private and public companies including Achieve3000, Amber Road (NYSE: AMBR), CytoSorbents (NASDAQ: CTSO), InstaMed, IntegriChain, and CareGain.  

Schedule
Networking: 5:30–6 p.m.
Talk: 6:00 p.m. 

Are you a biotech entrepreneur? Have you created a startup and would like more information about accounting and tax planning? Join our specialists from EisnerAmper, LLP for one-on-one discussions about accounting and tax planning for you and your company. Some of the topics you might consider taking advantage of during these meetings are:  

• Year-end tax planning
• Research and development credits
• Using research and development credits to reduce payroll tax expenses
• Cash basis vs. accrual basis tax reporting
• QuickBooks and other accounting software assistance
• Maximizing personal retirement contributions
• Entity structuring and ownership issues

Call us at 609.423.1540 to set up your appointment today!

EisnerAmper, LLP Specialists 
Tim O’Rourke is a partner in EisnerAmper’s Private Business Services Group. With more than twenty-five years f experience, Tim consults with clients regarding corporate and individual income tax planning, accounting, financial statement preparation, financial analysis, and business and personal financial planning. 

Charles Saydek is a senior manager in EisnerAmper’s Private Business Services Group. Charles has more than fifteen years of experience in public accounting, where he has specialized in business consulting, reviews, compilations, tax services, and retirement plan audits. 

Brian Trelstad, a partner at Bridges Fund Management based in New York City, will speak on the topic of impact investing.

Trelstad has more than ten years of impact investment experience, having served until 2012 as the chief investment office of Acumen Fund, where he oversaw $55m of investments into companies that were delivering health, water, energy, and agriculture services to economic base of the pyramid in South Asia and Sub-Saharan Africa.

He was a cofounding board member of the Aspen Network of Development Entrepreneurs and was one of the principal architects of impact management software tool, Pulse, and the Impact Reporting and Investment Standards. Prior to Acumen Fund, Trelstad worked as a consultant at McKinsey & Company, was a lead environmental staff person at the Corporation for National and Community Service, and was involved in a range of nonprofit and for-profit start ups.

Trelstad is an Entrepreneur in Residence with the Keller Center at Princeton University.

Schedule
Networking: 6–6:30 p.m.
Talk: 6:30 p.m.

There will be a Holiday Networking Event hosted by Princeton Tech Meetup on December 14, 2017 from 6:30pm - 8:45pm at the Princeton Public Library (Community Room - 1st Floor).

There will be expanded food and refreshments, and most of the floor will be open for networking. Around the perimeter of the room, we will have booths set up for sponsors and selected members to demo their products and services.

New Jersey Entrepreneurial Network's Company Valuations From An Entrepreneurs And An Investors Viewpoint will take place at TigerLabs, 232 Nassau Street, Princeton, NJ on December 13 from 5:00pm - 8:00pm.

Geoff Yang, cofounder of Redpoint Ventures and founder and principal of LaneOne, will discuss trends in tech investing. 

Yang has backed companies since their founding including, Arista, Ask.com, Bluefin, Calix, Efficient Frontier, Foundry Networks, Excite, Juniper Networks, Machinima, MySpace, and TiVo. He currently serves on the boards of Redpoint portfolio companies Electric Imp, Scribd, TasteMade, and Victorious; as well as AT&T, Esquel Group, and Franklin Resources (Franklin Templeton Funds). 

Currently chair of the Princeton Entrepreneurship Council Alumni Advisory Board, Yang has served as director of the National Venture Capital Association, president of the Western Association of Venture Capitalists, and a member of the President’s Information Technology Advisory Committee for the United States. He has also served as a member of the Advisory Council for the Stanford Graduate School of Business, chairman of the Stanford Engineering Venture Fund, 

He holds a BSE in engineering from Princeton University and an MBA from Stanford University.

Join us for a lunch presentation on precise methods in cell counting courtesy of ChemoMetec A/S. Learn about how easy it is to count cells on the NucleoCounter NC-200 and how it can help you standardize cell counting as your company grows.

This is a residents only event. 

On Wednesday, November 28, Princeton Innovation Center BioLabs will be awarded the "Innovator of the Year" award by the Princeton Regional Chamber of Commerce at its 2018 Annual Business Leadership Awards Gala.

Mike Wiley, vice president at New Jersey Health Foundation & Foundation Venture Capital Group, will discuss his organization’s impact investing funding model. He will also cover other impact-oriented investment models and sources of capital that entrepreneurs may want to consider to support the development and growth of their startups.

This is the first in a series on venture funding presented by Princeton Entrepreneurship Council.

Program Includes:

• Keynote by Dr. Donald C. Lo, NIH National Center for Advancing Translational Sciences 
• Case studies by Dr. Troy Messick, Wistar Institute, and Dr. Scott Kachlany, Rutgers University
• Dr. Bob DeVita Mount Sinai School of Medicine
• Dr. Krishnan Viswandham, vice president, BD & Global Alliances, Celgene Corporation
• Poster session
• Networking opportunities

Presented by the New Jersey Academic Drug Discovery Consortium.

New Jersey BioBreak is an invite-only group that holds regular networking events for life science executives. Their 1,200 active members share a common desire in building the New Jersey region into a thriving innovation hub. Their membership is a blend of pharmaceutical executives, entrepreneurs, academic researchers, and investors.

Attendance is free of charge for registered BioBreak members. There will be light appetizers and an open bar for each person who RSVPs prior to the event. 

A Science Panel Presented by BioLabs@CIC Philadelphia

Immunotherapy, or harnessing the body’s immune system to eliminate or slow the spread of disease, has the potential to upend conventional approaches for treating patients. Early results show improved outcomes and survival rates for people with certain types of cancers, leading to hopes that new drugs working in concert with the immune system may ultimately replace radiation and chemotherapy.

The panel will give their views on the promise of immuno-oncology, focusing on therapies and technologies now emerging from research labs.

Featured speakers include: 

• Peter Melley, director, New Ventures, University City Science Center (moderator)
• Dora Mitchell, PhD, vice president, operations, Carisma Therapeutics
• Dr. Ken Hance, senior director and head of immune biology, Immuno-Oncology and Combinations Discovery Performance Unit (IOC DPU), GlaxoSmithKline
• Matthew Cohen, principal, Osage University Partners
• Melina Blees, site director, BioLabs@CIC Philadelphia

The event is free and open to the public. Space is limited, so be sure to register now. 

BioNJ, the life sciences trade association for New Jersey, is offering a complimentary, one-year membership to resident life sciences companies in the Princeton Innovation Center BioLabs. The lunch & learn will offer an opportunity to learn about membership benefits associated with BioNJ, including cost savings programs, networking, along with access to talent and educational development programs.

This is a “Residents Only” event.

Join BioSapien for a 3D printing demonstration. Samples limited to one per company.

This is a “Residents Only” event. 

TechLaunch is shaking things up with a new, open/participatory model to replace the traditional investor pitch in which the startup is sequestered after pitching so that the panel can debate the merits of investing, behind closed doors. Instead, everything and everybody stays in the room. This way, all attendees will benefit from:

• Networking with other entrepreneurs & investors
  
• Hear live feedback to presenting startups
  
• Witnessing a mentored and vetted investor pitch
  
• Participating in the interaction between startups & investors

A presentation on Intellectual Property for emerging companies.

Muriel Liberto and Sean Grygiel from Mintz Levin will discuss all aspects of intellectual property including trademark, copyright, patents, and trade secrets and how IP can be a valuable business asset when developed early with a business focused strategy.

Program:

5:00 - 6:00pm — Check-in, Hors D'Oeuvres, Networking
6:00 - 7:00pm — Presentation and Discussion
7:00 - 7:45pm — Networking

Please register to let us know you are coming.

Princeton University and BioLabs are pleased to announce the Ribbon Cutting Ceremony and Reception at Princeton Innovation Center BioLabs

We look forward to developing an inclusive technology and life science startup ecosystem in central New Jersey.

Ribbon Cutting at 1:00 pm

BioNJ’s Eighth Annual BioPartnering Conference will take place at The Palace at Somerset Park, Somerset, New Jersey on Thursday, May 3rd.

The conference, which is developed in partnership with J.P. Morgan, brings more than 300 regional biopharmaceutical executives, investors, academic collaborators and business development professionals for a day of networking, 1-1 partnering meetings, company presentations, exhibits and plenary sessions.

Are you an entrepreneur? Do you want to change the world?

An exclusive preview of our NASA Collaborative National Event Series for 52 Ambitious Princeton Area HS Students.

A unique learning experience by Fizzee Labs:

- Complete in a game that builds your Innovation IQ
- Learn how successful entrepreneurs think and activate

Grand Prize:

13 Competitors will earn a spot in the NJ statement Tournament

Keynote Begins: 1pm

Keynote Speaker: Greg Olsen is an American scientist and entrepreneur, space tourist, and Princeton University Entrepreneur in Residence.

“How to get Funded” Series

Bert Marchio – Edge Therapeutics’ Chief Accounting Officer – talks about how they used state funding programs to grow Edge Therapeutics from startup to IPO.
Kamran Hashmi – NJ EDA – talks about the different state funding programs and what might be right for your company.

BioNJ’s Annual Dinner Meeting & Innovation Celebration, which is also the group's 25th anniversary, will take place on February 1, 2018.

Panel
Edward Bukstel - CEO, Clinical Blockchain
Soraya Ghebleh - Attorney - Hogan Lovells
Evin McMullen - Product Lead, Linnia / ConsenSys
Michael Sena - Product Head, uPort

Moderator
Ramesh Babu - Practice Head - FS Analytics and Blockchain, Wipro

Please join us for a media tour of the Princeton Innovation Center Biolabs, the newest effort by Princeton University to promote innovation and to support and grow the regional entrepreneurial ecosystem. This preview will include presentations by Johannes Fruehauf, Co-Founder and CEO of Biolabs, and Paul LaMarche, Vice Provost, Space Programming and Facilities at Princeton University, and Chairman of the Princeton Innovation Center, LLC.

The Princeton Innovation Center Biolabs, operated by Biolabs (headquartered in Cambridge, Massachusetts) provides co-working spaces specifically designed to meet the needs of the highest-potential science startups. The Center is available to companies formed by faculty, students and alumni, as well as by members of the wider New Jersey community. Located at Princeton Forrestal Center, the 31,000-square foot incubator offers a variety of shared space such as wet labs for chemical, biological and pharmaceutical development and dry lab space for engineering development, as well as shared office and desk space for resident companies and related ventures. The Center, which opened this month, is equipped with a broad array of premium scientific equipment and will offer additional services and amenities for resident companies.

The newly renovated space is strategically designed to promote collaboration and help startups go further and faster on limited investment capital, enabling a potentially shorter path from proof-of-concept to commercialization. Princeton Innovation Center Biolabs will also host regular educational programming and community networking events. There is ample free parking available.

Media Contacts
Princeton: Michael Hotchkiss, mh14@princeton.edu
Biolabs: Caroline Grossman caroline@biolabs.io

Please RSVP by noon Wednesday, Jan 24th, to Michael Hotchkiss:

Cofounder and Executive Chairman Dr. Steve Sun grew GENEWIZ, a leading global genomics service provider, from a two-person biotech startup to an international operation employing more than 1,000 people across 12 facilities around the world. GENEWIZ was acquired in September for $450 million.

Sun will share his GENEWIZ story, followed by a Q&A.

Schedule 
5:30–6:00 p.m., Networking
6:00 p.m., Fireside Chat

This is a collaborative event by the Commercialization Center for Innovative Technologies (CCIT) and Princeton Innovation Center BioLabs. For more information on CCIT, contact Lenzie Harcum. For more information on Princeton Innovation Center BioLabs, contact Nishta Rao.

Health 2.0's Diversifying Digital Health event will take place at The Farm in Soho, New York, NY on January 22, 2018.

Join this event to dig into the topic of diversity in the digital health space. The goal of this meet-up is to foster an honest and frank discussion about how we can create diverse workplaces and develop inclusive technology for the people we serve.

The 2018 Small Business Contracts & Capital Sourcing Expo is taking place at Rutgers, Newark, NJ on January 12, 2018 from 8:00am - 1:00pm.

This is a business-to-business-to-consumer networking event. Entrepreneurs and small businesses are given an opportunity to market, promote and sell their products or services to a diverse audience. The Expo is a great way to increase sales and directly market to consumers.